2.3103.75% ( -0.090 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 90.96, within the reasonable range, cheaper than 21.37% of the time in the past 1 years, and the industry ranks 15/21, the industry Median 8.72.
90.96xP/E
HK$2.31Stock price
HK$0.03Earnings per share
90.96xP/E
Stock priceHK$2.31Earnings per shareHK$0.03
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -176.31x
- Typical range
- -453.11x–98.45x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.72x
023466992
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.72x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
02609HKBAYZED HEALTH | 90.96x | -- | HK$3.05B |
00383HKTIANAN MEDICARE | 97.92x | -- | HK$838.74M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
